Organization
Deepa Jagadeesh
3 clinical trials
Clinical trial
An Open-Label, Phase I/II Study of ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell LymphomaStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Clinical trial
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)Status: Recruiting, Estimated PCD: 2024-06-15
Clinical trial
Phase II Study of Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder (PTLD)Status: Terminated, Estimated PCD: 2022-06-27